Tag:

WuXi PharmaTech, China's largest CRO (contract research organization), agreed to a $3.3 billion buyout deal that would take it off of Wall Street and into the hands of some private investors. Pending shareholder approval, the Shanghai-headquartered company will cease its U.S. listing in the fourth quarter of this year, selling itself to a newly formed parent company in an all-cash deal...

Testing on an edible on-dose authentication technology developed by TruTag Technologies is showing promising results for its use in combating counterfeit drugs…TruTech partnered with WuXi PharmaTech,…technology that can store a drug’s provenance information on individual tablets. The silica, dust particle-sized TruTags act like bar codes that can provide information about where a drug was manufactured and its dosage, as well as supply chain details like lot or batch number...